Kyung Nam Pharm Co.,Ltd.

A053950

KR7053950002

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
1,044 ^KRW	-.--%		-7.45%	-37.93%

2023	Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding	CI
2023	Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding	CI

Kyung Nam Pharm Co., Ltd. announced that it has received KRW 10.534998926 billion in funding

November 13, 2018

On November 14, 2018, Kyung Nam Pharm Co., Ltd. (KOSDAQ:A053950) closed the transaction. The company issued 1,051,607 shares for gross proceeds of KRW 10,534,998,926.

Latest news about Kyung Nam Pharm Co.,Ltd.

Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding	23-09-21	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding	23-09-17	CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding	23-08-09	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding	23-07-16	CI
Kyung Nam Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Kyung Nam Pharm Co.,Ltd. agreed to acquire 9.94% stake in ILYA Co., Ltd from Kang, Jae Woo and Han, Seung Ja for KRW 7 billion.	23-03-14	CI
Enterpartners Co., LTD announced that it expects to receive KRW 26.599899939 billion in funding from Kyung Nam Pharm Co.,Ltd.	22-11-13	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD.	21-12-23	CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 8 billion in funding from Metaplex Co., Ltd., and other investors	21-12-09	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 8 billion in funding from Metaplex Co., Ltd., and other investors	21-11-29	CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	21-07-19	CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	21-07-11	CI
Kyung Nam Pharm Co.,Ltd., Virtualtek Corp and Ventage Partners Co., Ltd. agreed to acquire 9.32% stake in Livefinancial Co.,Ltd. for KRW 5.8 billion.	20-07-15	CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 1.9999997 billion in funding from KyungNam Biopharma CO.,LTD.	20-06-30	CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors	20-06-09	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors	20-06-03	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 1.9999997 billion in funding from BioGenetics CO.,LTD.	20-03-29	CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 20.49998703 billion in funding from BioGenetics CO.,LTD., Liveplex Co.,Ltd., CTGen Co.,Ltd., Widwin Investment Co., Ltd.	19-05-22	CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 6.49999411 billion in funding from BioGenetics CO.,LTD.	19-05-20	CI
BioGenetics CO.,LTD. acquired additional unknown stake in Kyung Nam Pharm Co.,Ltd. for KRW 22.5 billion.	19-05-12	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 20.49998703 billion in funding from BioGenetics CO.,LTD., Liveplex Co.,Ltd., CTGen Co.,Ltd., Widwin Investment Co., Ltd.	19-05-12	CI
Kyung Nam Pharm Co., Ltd. announced that it has received KRW 10.534998926 billion in funding	18-11-13	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 6.499998976 billion in funding from BioGenetics CO.,LTD.	18-11-13	CI
Kyung Nam Pharm Co., Ltd. announced that it expects to receive KRW 16.99999501 billion in funding	18-10-14	CI
KMH Akyung Group cancelled the acquisition of unknown stake in Kyung Nam Pharm Co., Ltd..	18-06-28	CI

Chart Kyung Nam Pharm Co.,Ltd.

Duration

Period

More charts

KYUNG NAM PHARM.CO., LTD. is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company's product portfolio consists of vitamin products, placenta products, health food products and general pharmaceuticals. The Company provides vitamin products under the brand name LEMONA. It supplies health food products such as lactobacillus products through convenient stores and marts. The placenta products include human placenta related injections and drinks. The general pharmaceuticals include athlete foot therapeutic agents, inflammatory drugs, cold remedies, multi-nutrients and others.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
KYUNG NAM PHARM CO.,LTD.	-37.93%	26.87M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.40%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.12%	14B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-9.58%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B